166 related articles for article (PubMed ID: 17374617)
41. Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.
Lanteri M; Ollier L; Giordanengo V; Lefebvre JC
Breast Cancer Res; 2005; 7(4):R487-94. PubMed ID: 15987454
[TBL] [Abstract][Full Text] [Related]
42. SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTn.
Kircheis R; Vondru P; Nechansky A; Ohler R; Loibner H; Himmler G; Mudde GC
Bioconjug Chem; 2005; 16(6):1519-28. PubMed ID: 16287250
[TBL] [Abstract][Full Text] [Related]
43. Induction of B-cell tolerance by retroviral gene therapy.
Bracy JL; Iacomini J
Blood; 2000 Nov; 96(9):3008-15. PubMed ID: 11049978
[TBL] [Abstract][Full Text] [Related]
44. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
Skornick Y; Kurman CC; Sindelar WF
Cancer Res; 1984 Mar; 44(3):946-8. PubMed ID: 6692417
[TBL] [Abstract][Full Text] [Related]
45. An O-acetylated sialyl-Tn is involved in ovarian cancer-associated antigenicity.
Toba S; Tenno M; Kurosaka A
Biochem Biophys Res Commun; 2000 May; 271(2):281-6. PubMed ID: 10799288
[TBL] [Abstract][Full Text] [Related]
46. Binding of human natural antibodies to nonalphaGal xenoantigens on porcine erythrocytes.
Zhu A
Transplantation; 2000 Jun; 69(11):2422-8. PubMed ID: 10868652
[TBL] [Abstract][Full Text] [Related]
47. Possible presence of O-linked carbohydrate in the human male reproductive tract CD52.
Hasegawa A; Sawai H; Tsubamoto H; Hori M; Isojima S; Koyama K
J Reprod Immunol; 2004 Jun; 62(1-2):91-100. PubMed ID: 15288185
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
Dziadek S; Kunz H
Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
[TBL] [Abstract][Full Text] [Related]
49. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal.
Cretin N; Bracy J; Hanson K; Iacomini J
J Immunol; 2002 Feb; 168(3):1479-83. PubMed ID: 11801692
[TBL] [Abstract][Full Text] [Related]
50. Evidence for structurally conserved recognition of the major carbohydrate xenoantigen by natural antibodies.
Ramsland PA; Farrugia W; Yuriev E; Edmundson AB; Sandrin MS
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):307-17. PubMed ID: 12887109
[TBL] [Abstract][Full Text] [Related]
51. Comparison of carbohydrate and peptide biotinylation on the immunological activity of IgG1 murine monoclonal antibodies.
Miralles F; Takeda Y; Escribano MJ
J Immunol Methods; 1991 Jul; 140(2):191-6. PubMed ID: 2066565
[TBL] [Abstract][Full Text] [Related]
52. The role of complement receptors in production of antibodies specific for Galalpha1,3Gal.
Kaye J; Bagley J; Malkowski D; Iacomini J
Transplantation; 2004 Jan; 77(2):314-6. PubMed ID: 14743001
[TBL] [Abstract][Full Text] [Related]
53. Recombinant breast carcinoma-associated mucins expressed in a baculovirus system contain a tumor specific epitope.
Hu P; Wright SE
Immunotechnology; 1998 Oct; 4(2):97-105. PubMed ID: 9853951
[TBL] [Abstract][Full Text] [Related]
54. Forskolin increases the expression of the pancreatic tumor antigen, Nd2, and uptake of Nd2 antibody.
Ho JJ; Farrelly ER; Hong J; Pan P; Kim YS
Int J Oncol; 2000 Nov; 17(5):881-7. PubMed ID: 11029487
[TBL] [Abstract][Full Text] [Related]
55. Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.
Koike C; Uddin M; Wildman DE; Gray EA; Trucco M; Starzl TE; Goodman M
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):559-64. PubMed ID: 17194757
[TBL] [Abstract][Full Text] [Related]
56. [Introduction of a new laboratory marker for cancer of the pancreas (CA 19.9). Current experience].
Nunes AP; Jukemura J; Machado MC; Scheinberg MA
Rev Paul Med; 1986; 104(2):99-101. PubMed ID: 3468583
[No Abstract] [Full Text] [Related]
57. Further characterization of the binding properties of two monoclonal antibodies recognizing human Tn red blood cells.
Wua AM; Wub JH; Kuoa HW; Herpa A
J Biomed Sci; 2005; 12(1):153-66. PubMed ID: 15864747
[TBL] [Abstract][Full Text] [Related]
58. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.
Lan MS; Finn OJ; Fernsten PD; Metzgar RS
Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141
[TBL] [Abstract][Full Text] [Related]
59. [Use of monoclonal antibodies in the treatment of cancer of the pancreas: towards new progress?].
Bellet D; Bidart JM; Rougier P; Bohuon C
Bull Cancer; 1990; 77(3):283-8. PubMed ID: 2187547
[TBL] [Abstract][Full Text] [Related]
60. Molecular changes in carbohydrate antigens associated with cancer.
Singhal A; Hakomori S
Bioessays; 1990 May; 12(5):223-30. PubMed ID: 1695095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
